我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
15
3 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
进行中(未招募)
2
13.3%
已完成
尚未招募
1
6.7%
招募中
7
46.7%
终止
3
20.0%
暂无批准数据
- Researchers at RMIT University have developed nanodots made from molybdenum oxide that selectively kill cancer cells while largely sparing healthy tissue. - Laboratory tests demonstrated the nanodots destroyed three times more cervical cancer cells than healthy cells within 24 hours without requiring light activation. - The particles work by releasing reactive oxygen molecules that trigger programmed cell death in cancer cells, which are already under higher stress than healthy cells. - The research represents an international collaboration between RMIT University, The Florey Institute, and several Chinese institutions, though testing remains limited to laboratory-grown cells.